miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
出版年份 2018 全文链接
标题
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-30
DOI
10.1038/s41388-018-0459-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer
- (2018) Yunxiao Meng et al. CANCER LETTERS
- Molecular mechanisms of drug resistance in ovarian cancer
- (2018) Leyla Norouzi-Barough et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance
- (2018) Wei Zhou et al. ONCOGENE
- MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
- (2017) Shichang Cui et al. Molecular Medicine Reports
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12
- (2016) SU DONG et al. ONCOLOGY REPORTS
- Targeting c-MYC in Platinum-Resistant Ovarian Cancer
- (2015) J. M. Reyes-Gonzalez et al. MOLECULAR CANCER THERAPEUTICS
- microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR
- (2015) Yingwei Luo et al. TUMOR BIOLOGY
- The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma
- (2015) Euan A. Stronach et al. Oncotarget
- Dual Oxidase Maturation factor 1 (DUOXA1) overexpression increases reactive oxygen species production and inhibits murine muscle satellite cell differentiation
- (2014) Shelley DE Sandiford et al. Cell Communication and Signaling
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137
- (2014) Alix Warburton et al. SCHIZOPHRENIA BULLETIN
- Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
- (2014) Kouji Banno et al. Biomed Research International
- Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity
- (2013) X Zhao et al. LEUKEMIA
- Overcoming Platinum Resistance in Preclinical Models of Ovarian Cancer Using the Neddylation Inhibitor MLN4924
- (2013) A. A. Jazaeri et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
- (2013) Rossella Marullo et al. PLoS One
- EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
- (2012) Francesco Crea et al. CANCER AND METASTASIS REVIEWS
- miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
- (2012) M T M van Jaarsveld et al. ONCOGENE
- Differential Gene and MicroRNA Expression between Etoposide Resistant and Etoposide Sensitive MCF7 Breast Cancer Cell Lines
- (2012) Karobi Moitra et al. PLoS One
- miRNAs as mediators of drug resistance
- (2012) Sierk Haenisch et al. Epigenomics
- Role of microRNAs in lymphoid biology and disease
- (2011) Muller Fabbri et al. CURRENT OPINION IN HEMATOLOGY
- Myc Regulates the Transcription of the PRC2 Gene To Control the Expression of Developmental Genes in Embryonic Stem Cells
- (2011) F. Neri et al. MOLECULAR AND CELLULAR BIOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Regulation of Deoxycytidine Kinase Expression and Sensitivity to Gemcitabine by Micro-RNA 330 and Promoter Methylation in Cancer Cells
- (2011) Jasmina Hodzic et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance
- (2011) S. Pyndiah et al. Science Signaling
- Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
- (2010) Sha Hu et al. CANCER BIOLOGY & THERAPY
- p27Kip1Mediates Addiction of Ovarian Cancer Cells toMYCC(c-MYC) and Their Dependence onMYCParalogs
- (2010) Tulsiram Prathapam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA-137 Targets Microphthalmia-Associated Transcription Factor in Melanoma Cell Lines
- (2008) L. T. Bemis et al. CANCER RESEARCH
- MicroRNAs modulate the chemosensitivity of tumor cells
- (2008) P. E. Blower et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now